Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/17417
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKumar, R.en
dc.contributor.authorNeilsen, P.en
dc.contributor.authorCrawford, J.en
dc.contributor.authorMcKirdy, R.en
dc.contributor.authorLee, J.en
dc.contributor.authorPowell, J.en
dc.contributor.authorSaif, Z.en
dc.contributor.authorMartin, J.en
dc.contributor.authorLombaerts, M.en
dc.contributor.authorCornelisse, C.en
dc.contributor.authorCleton-Jansen, A.en
dc.contributor.authorCallen, D.en
dc.date.issued2005en
dc.identifier.citationCancer Research, 2005; 65(24):11304-11313en
dc.identifier.issn0008-5472en
dc.identifier.issn1538-7445en
dc.identifier.urihttp://hdl.handle.net/2440/17417-
dc.description.abstractA BAC located in the 16q24.3 breast cancer loss of heterozygosity region was previously shown to restore cellular senescence when transferred into breast tumor cell lines. We have shown that FBXO31, although located just distal to this BAC, can induce cellular senescence in the breast cancer cell line MCF-7 and is the likely candidate senescence gene. FBXO31 has properties consistent with a tumor suppressor, because ectopic expression of FBXO31 in two breast cancer cell lines inhibited colony growth on plastic and inhibited cell proliferation in the MCF-7 cell line. In addition, compared with the relative expression in normal breast, levels of FBXO31 were down-regulated in breast tumor cell lines and primary tumors. FBXO31 was cell cycle regulated in the breast cell lines MCF-10A and SKBR3 with maximal expression from late G2 to early G1 phase. Ectopic expression of FBXO31 in the breast cancer cell line MDA-MB-468 resulted in the accumulation of cells at the G1 phase of the cell cycle. FBXO31 contains an F-box domain and is associated with the proteins Skp1, Roc-1, and Cullin-1, suggesting that FBXO31 is a component of a SCF ubiquitination complex. We propose that FBXO31 functions as a tumor suppressor by generating SCFFBXO31 complexes that target particular substrates, critical for the normal execution of the cell cycle, for ubiquitination and subsequent degradation. (Cancer Res 2005; 65(24): 11304-313)en
dc.description.statementofresponsibilityRaman Kumar, Paul M. Neilsen, Joanne Crawford, Ross McKirdy, Jaclyn Lee, Jason A. Powell, Zarqa Saif, Julie M. Martin, Marc Lombaerts, Cees J. Cornelisse, Anne-Marie Cleton-Jansen, and David F. Callenen
dc.language.isoenen
dc.publisherAmer Assoc Cancer Researchen
dc.rights© 2005 American Association for Cancer Researchen
dc.subjectKidney; Tumor Cells, Cultured; Chromosomes, Artificial, Bacterial; Chromosomes, Human, Pair 16; Humans; Breast Neoplasms; Cullin Proteins; Carrier Proteins; F-Box Proteins; Cell Cycle Proteins; Tumor Suppressor Proteins; Blotting, Northern; Colony-Forming Units Assay; Immunoprecipitation; G1 Phase; G2 Phase; Cell Proliferation; Genes, Tumor Suppressor; Female; Cellular Senescenceen
dc.titleFBXO31 is the chromosome 16q24.3 senescence gene, a candidate breast tumor suppressor, and a component of an SCF complexen
dc.typeJournal articleen
dc.identifier.rmid0020052270en
dc.identifier.doi10.1158/0008-5472.CAN-05-0936en
dc.identifier.pubid53766-
pubs.library.collectionPaediatrics publicationsen
pubs.verification-statusVerifieden
pubs.publication-statusPublisheden
dc.identifier.orcidCallen, D. [0000-0002-6189-9991]en
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.